Home

Insights

Dr Reddys Laboratories Ltd dividend

Dr Reddys Laboratories Ltd dividend

download
stocks purchased

₹ 3.3 Cr

Volume transacted

stocks purchased

5.7 K

stocks traded

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

DPS

40

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Dr Reddys Laboratories Ltd is ₹ 40 as of 2023 .a1#The Dividend Payout of Dr Reddys Laboratories Ltd changed from 25.99 % on March 2019 to 25.51 % on March 2023 . This represents a CAGR of -0.37% over 5 years. a1#The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 5835 as of 22 May 11:15 .a1#The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 46069 crore on March 2019 to ₹ 76960 crore on March 2023 . This represents a CAGR of 10.81% over 5 years. a1#The Revenue of Dr Reddys Laboratories Ltd changed from ₹ 6096 crore to ₹ 7314 crore over 8 quarters. This represents a CAGR of 9.54% a1#The EBITDA of Dr Reddys Laboratories Ltd changed from ₹ 1804 crore to ₹ 2032 crore over 8 quarters. This represents a CAGR of 6.12% a1#The Net Profit of Dr Reddys Laboratories Ltd changed from ₹ 1189 crore to ₹ 1309 crore over 8 quarters. This represents a CAGR of 4.96% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield

swot
swot

Fundamental Metrics

Market Cap

98,732 Cr

EPS

334.4

P/E Ratio (TTM) *

17.7

P/B Ratio (TTM) *

3.5

DTE *

0.1

ROE *

19.7

ROCE *

24.1

Dividend Yield *

0.87

DPS *

40

Dividend Payout *

25.51

Ann.Dividend % *

800

* All values are consolidated

* All values are consolidated

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1926
Mar '2014
Mar '2119
Mar '2231
Mar '2326

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

PRICE

5835.25

54.55(0.94%)

stock direction

Last updated : 22 May 11:15

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Dividend Overview for Dr Reddys Laboratories Ltd

  • Dr Reddys Laboratories Ltd, boasts of a market capitalization of Rs 98732 Cr., with a share price of Rs 5835.25 as of 22 May 11:15. While all stocks don't consistently pay dividends, Dr Reddys Laboratories Ltd rewarded its shareholders, distributing 25.5 % for the full year.
  • In the year ending 2022, Dr Reddys Laboratories Ltd declared a dividend of Rs 30, resulting in a dividend yield of 0.7% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Dr Reddys Laboratories Ltd recorded revenues of Rs 27916 Cr, with a trailing EBITDA Margin of 31.7% and net-profit of Rs 5578 Cr

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1946069
Mar '2051798
Mar '2175095
Mar '2271653
Mar '2376961

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '226096
Sep '226387
Dec '226855
Mar '226461
Jun '236936
Sep '237222
Dec '237456
Mar '237315

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '221805
Sep '221954
Dec '222003
Mar '221680
Jun '232240
Sep '232328
Dec '232242
Mar '232032

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '221189
Sep '221114
Dec '221244
Mar '22960
Jun '231405
Sep '231482
Dec '231381
Mar '231310

* All values are a in crore

About Dr Reddys Laboratories Ltd

About Dr Reddys Laboratories Ltd

    Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. In the year 1993, the company established Dr. Reddy's Research Foundation and initiated drug discovery programme. In the year 2003, they launched Ibuprofen, first generic product to be marketed under the 'Dr. Reddy's' label in the US. During the year 2010-11, the company acquired GlaxoSmithKline's (GSK) oral penicillin manufacturing facility located in Tennessee, USA. During the year, the company launched Cresp in India, the first biosimilar darbepoetin alfa in the world. This action follows the earlier inspections of these sites by the agency in November 2014, January 2015 and February 2015 respectively. On 8 February 2017, Dr. Reddy's Laboratories Ltd announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France. It is intended to be used for the prevention of surgical site infections, following non-emergency, elective colorectal surgery. Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. This entire portfolio has been transferred to the Company, along with related sales and marketing teams, the manufacturing plant located in Baddi, Himachal Pradesh, and employees. Based on the forensic investigation, no evidence was found of any data breaches leading to personally identifiable information. As of March 31, 2022, there were 90 generic filings awaiting approval with the US Food and Drug Administration (USFDA), comprising 87 ANDAs and 3 NDAs. Dr. Reddy's (WUXI) Pharmaceutical Co. Limited in China ceased to be a step-down subsidiary of the Company with effect from December 13, 2021, consequent to its liquidation.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddy’s Lab Andhra Pradesh facility gets 2 USFDA observations

The drug regulator conducted good manufacturing practice (GMP) inspection at its formulati...

Read more

18 May 2024 08:33

News

Dr Reddys Laboratories AGM scheduled

Dr Reddys Laboratories announced that the 40th Annual General Meeting(AGM) of the company ...

Read more

07 May 2024 16:41

News

Board of Dr Reddys Laboratories recommends final dividend

Dr Reddys Laboratories announced that the Board of Directors of the Company at its meeting...

Read more

07 May 2024 16:41

News

Dr Reddy's Q4 PAT jumps 36% YoY to Rs 1,307 crore

The revenue growth was largely driven by growth in global generics revenues in North Ameri...

Read more

07 May 2024 17:26

News

Dr Reddy's Labs launches generic Oracea capsules in US markets

Oracea is a tetracycline antibiotic. It is used to treat blemishes, bumps, and acne-like l...

Read more

06 May 2024 09:29

News

Dr Reddy's launches Doxycycline Capsules in the US

Dr. Reddy's Laboratories announced its launch of Doxycycline Capsules, 40 mg in the U.S. m...

Read more

03 May 2024 15:50

FAQs for dividends of Dr Reddys Laboratories Ltd

What is the current market price of Dr Reddys Laboratories Ltd Ltd as of May 22, 2024?

The current market price of Dr Reddys Laboratories Ltd Ltd stands at 5835.3 per share.

What dividend did Dr Reddys Laboratories Ltd declare in the last fiscal year?

In the last fiscal year, Dr Reddys Laboratories Ltd declared a dividend totaling ₹40.0.

What is the most recent dividend declared by Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Dr Reddys Laboratories Ltd declared dividends in the current fiscal year

Dr Reddys Laboratories Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Dr Reddys Laboratories Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Dr Reddys Laboratories Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199